4//SEC Filing
Narula Sanjeev 4
Accession 0001193125-26-001123
CIK 0001783183other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:42 PM ET
Size
7.3 KB
Accession
0001193125-26-001123
Insider Transaction Report
Form 4
Narula Sanjeev
Chief Financial & Bus. Officer
Transactions
- Award
Common Stock
2026-01-02+82,715→ 226,715 total - Award
Stock Option (Right to Buy)
2026-01-02+42,848→ 42,848 totalExercise: $15.71Exp: 2036-01-01→ Common Stock (42,848 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted on January 2, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of January 2, 2026, the vesting commencement date (the "Vesting Commencement Date"), subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]1/48th of the total number of shares of common stock subject to the option vest monthly following the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001820590
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 5:42 PM ET
- Size
- 7.3 KB